Biocon Ltd Financials
Company Logo

Biocon Ltd Financial Statement

Biocon Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue552.50
Operating Expense465.70
Net Profit0.90
Net Profit Margin0.16
Earning Per Share0.01
EBIDTA89.00
Effective Tax Rate2.76

Biocon Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2,127.30
Operating Expenses Annual1,864.60
Operating Profit Annual470.20
Interest Annual198.80
Depreciation114.10
Net Profit Annual119.30
Tax Annual31

Biocon Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning196.60
Cash Flow from Operations-123.20
Cash Flow from Investing-294.70
Cash Flow from Financing343.60
Cash Flow at the End122.30

Biocon Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)21.31
PBIT Margin (%)15.62
PBT Margin (%)15.54
Net PROFIT Margin (%)5.61
Return On Networth / Equity (%)0.97
Return On Networth /Employed (%)2.61
Return On Assets (%)0.95
Total Debt / Equity (X)0.15
Asset Turnover Ratio (%)0.17

Biocon Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual915
Total Current Assets Annual2,760
Non Current Assets Annual11,008.20
Total Shareholders Funds Annual10,912.30
Total Assets Annual13,768.20

Biocon Ltd Earning Calls

EPS (INR)

Expected

5.49

Reported

5.51

Surprise

0.36%

Mar 2024

EPS beaten by 0.36%

Dec 2023

EPS beaten by 0.00%

Sep 2023

EPS beaten by 0.36%

Get Your FAQs Right

As of Oct 9, 2024, Biocon Ltd has a market capitalization of 31,707.85 Cr. Value Research classifies it as a Large-Cap company.
Yes, Biocon Ltd is debt-free with a debt-to-equity ratio of 0.19.
In FY 2023 , Biocon Ltd recorded a total revenue of approximately 2,127.30 Cr marking a significant milestone in the company's financial performance.
Biocon Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..
Biocon Ltd's current PE ratio is 265.78.
Biocon Ltd's ROCE averaged 1.9% from the FY ending March 2022 to 2024, with a median of 1.7%. It peaked at 2.7% in March 2024, reflecting strong capital efficiency over the period..
Biocon Ltd's latest EBIT is Rs. 349.10 Cr, surpassing the average EBIT of Rs. 1,176.67 Cr over the 5 years..